The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux
-
摘要: 目的:探讨质子泵抑制剂(PPI)治疗咽喉反流(LPR)患者声嘶症状的疗效。方法:60例以声嘶为主诉LPR患者,随机分为A、B两组:A组(30例)给予金嗓开音胶囊治疗(1.2 g/次,2次/d,口服,连用3个月);B组(30例)在A组的基础上同时加用奥美拉唑治疗(20 mg/次,2次/d,口服,连用3个月)。在治疗前和治疗后1、2、3个月分别记录以下数据:反流症状指数(RSI),反流体征指数(RFS)和嗓音障碍指数(VHI),比较A、B两组上述参数变化的差异。结果:60例患者治疗前RSI和RFS分别与VHI评分比较,均呈显著正相关(r=0.823,P<0.01;r=0.873,P<0.01)。与治疗前相比,B组治疗后1、2、3个月的RSI和VHI的评分变化显著高于A组,差异有统计学意义(P<0.01)。B组治疗后1、2个月的RFS评分与A组比较差异无统计学意义(t=1.128,P>0.05;t=0.376,P>0.05),但治疗后3个月RFS评分显著高于A组(t=8.307,P<0.01)。结论:PPI治疗可显著改善LPR患者的声嘶症状。Abstract: Objective:To analyze the therapeutic effect of proton pump inhibitor(PPI) on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux(LPR). Method:The LPR outpatients in ENT department of our hospital(60 cases)complained of hoarseness were enrolled in the study from August of 2013 to October of 2014. All of them were randomly divided into group A and B. The individuals in group A (30 cases) taked golden voice capsule to treat for 3 months, while the individuals in group B (30 cases) taked golden voice capsule and omeprazole to treat for 3 months. The data about reflux symptom index (RSI), reflux finding score (RFS) and voice handicap index (VHI)from the first month to the third month after treatment were recorded and compared group A with group B.Result:The scores of RSI and RFS in patients (60 cases) before treatment were significantly correlated with their VHI (r=0.823, P<0.01; r=0.873, P<0.01).The score changes of RSI and VHI from the first to the third month after treatment in group B were significantly higher than those in group A (P<0.01). Meanwhile, the score changes of RFS from the third month after treatment in group B were significantly higher than those in group A (t=8.307,P<0. 01), but the differences were not significant for RFS from the first to the second month after treatment between group A and group B(t=1.128,P>0.05;t=0.376,P>0.05).Conclusion:PPI therapy could significantly alleviate the hoarseness symptom in LPR patients.
-
Key words:
- hoarseness /
- laryngopharyngeal reflux /
- proton pump inhibitor
-
[1] KOUFMAN J A,AVIV J E,CASIANO R R,et al.Laryngopharyngeal reflux:position statement of the committee on speech,voice,and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery[J].Otolaryngol Head Neck Surg,2002,127:32-35.
[2] 张立红,郑宏伟,余力生,等.咽喉反流及胃食管反流在喉癌前病变及喉癌发生中的作用[J].中国耳鼻咽喉头颈外科,2009,16(8):433-435.
[3] 严森,徐文,李赟,等.咽喉反流与嗓音疾病的相关分析[J].听力学及言语疾病杂志,2014,22(1):34-38.
[4] 李丽娜,张延平,周凤书,等.咽喉反流与声带息肉之间的相关性研究[J].中国耳鼻咽喉颅底外科杂志,2012,18(6):431-433.
[5] BELAFSKY P C,POSTMA G N,KOUFMAN J A.Validity and reliability of the reflux symptom index(RSI)[J].J Voice,2002,16:274-277.
[6] BELAFSKY P C,POSTMA G N,KOUFMAN J A.The validity and reliability of the reflux fingding score(RFS)[J].Laryngoscope,2001,118:1313-1317.
[7] 徐文,李红艳,胡蓉,等.嗓音障碍指数量表中文版信度和效度评价[J].中华耳鼻咽喉头颈外科杂志,2008,43(9):670-675.
[8] COHEN S M,GARRETT C G.Hoarseness:is it really laryngopharyngeal reflux[J]?Laryngoscope,2008,118:363-366.
[9] SCHWARTZ S R,COHEN S M,DAILEY S H,et al.Clinical practice guidline:hoarseness(dysphonia)[J].Otolaryngol Head Neck Surg,2009,141:S1-S31.
[10] 徐志鸿,何锦添,钟景良,等.声带息肉与咽喉反流的相关性研究[J].实用医学杂志,2013,29(11):1805-1807.
[11] BLOCK B B,BRODSKY L.Hoarseness in children:the role of laryngopharyngeal reflux[J].Int J Pediatr Otorhinolaryngol,2007,71:1361-1369.
[12] THOMAS J P,ZUBIAUR F M.Over-diagnosis of laryngopharyngeal reflux as the cause of hoarseness[J].Eur Arch Otorhinolaryngol,2013,270:995-999.
[13] OZTURK O,OZ F,KARAKULLUKCU B,et al.Hoarseness and laryngopharyngeal reflux:a cause and effect relationship or coincidence[J]?Eur Arch Otorhinolaryngol,2006,263:935-939.
[14] WIENER G J,KOUFMAN J A,WU W C,et al.Chronic hoarseness secondary to gastroesophageal reflux disease:documentation with 24-h ambulatory pH monitoring[J].Am J Gastroenterol,1989,84:1503-1508.
[15] ORMSETH E J,WONG R K.Reflux laryngitis:pathophysiology,diagnosis,and management[J].Am J Gastroenterol,1999,94:2812-2817.
[16] LUO H N,YANG Q M,ZHANG Q,et al.Role of pepsin and pepsinogen:linking laryngopharyngeal reflux with otitis media with effusion in children[J].Laryngoscope,2014,124:E294-300.
[17] REICHEL O,MAYR D,DURST F,et al.E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux[J].Eur Arch Otorhinolaryngol,2008,265:937-942.
[18] BORKOWSKI G,SUDHOFF H,KOSLOWSKI F,et al.A possible role of Helicobacter pylori infection in the etiology of chronic laryngitis[J].Eur Arch Otorhinolaryngol,1997,254:481-482.
[19] 李湘平,吴婷,王路,等.埃索美拉唑治疗咽喉反流的疗效评估[J].临床耳鼻咽喉头颈外科杂志,2011,25(9):388-391.
[20] 冉向群,赵兴宇,童红霞,等.奥美拉唑联合多潘立酮治疗喉咽反流性疾病临床观察[J].临床耳鼻咽喉头颈外科杂志,2010,24(3):137-138.
[21] 王军,高刚,马莉.抑酸药物治疗时间对咽喉反流疾病的疗效影响[J].临床耳鼻咽喉头颈外科杂志,2011,25(18):857-858.
[22] NOORDZIJ J P,KHIDR A,EVANS B A,et al.Evaluation of omeprazole in the treatment of reflux laryngitis:a prospective,placebo-controlled,randomized,double-blind study[J].Laryngoscope,2001,111:2147-2151.
[23] ORIDATE N,TAKEDA H,ASAKA M,et al.Acidsuppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients[J].Dig Dis Sci,2008,53:2033-2038.
[24] ORIDATE N,TAKEDA H,YAMAMOTO J,et al.Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms[J].Laryngoscope,2006,116:547-553.
[25] RODRIGUEZ-TELLEZ M,GALERA-RUIZ H,ARGUELLES-ARIAS F,et al.Posterior laryngitis:effects of treatment with omeprazole alone[J].Rev Esp Enferm Dig,2002,94:123-130.
[26] 张立红,李娜,郑宏伟,等.咽喉反流的初步研究[J].中华耳鼻咽喉头颈外科杂志,2009,44(2):105-108.
计量
- 文章访问数: 44
- PDF下载数: 27
- 施引文献: 0